Governance – Health Technology Assessment Central

ISPOR HTA Council

The ISPOR Health Technology Assessment (HTA) Council is a global body of healthcare decision makers that advises the Society toward the goal of bridging the gap between outcomes research and healthcare decision making. The Society’s HTA Roundtables convene HTA experts and are held in the 5 geographic regions in which each roundtable focuses.

HTA Council Chair

Professor Finn Børlum Kristensen, MD, PhD
Professor, Faculty of Health Sciences,
University of Southern Denmark
Odense, Denmark

HTA Roundtable Chairs

HTA Roundtable–Asia Pacific (2016-2019)

Sukyeong Kim, PhD, RPh, MPH
Senior Research Fellow, Evidence-Based Healthcare Research Department
National Evidence-Based Healthcare Collaborating Agency (NECA)
Seoul, South Korea

HTA Roundtable–Europe (2017-2020)

Wim Goettsch, PhD, MSc
Special Advisor, Health Technology Assessment
Zorginstituut Nederland
Diemen, Netherlands

HTA Roundtable–Latin America (2016-2019)

Aurelio Mejía, MSc
Researcher, Health Economics and HTA and Lecturer Fundación Universitaria de Ciencias de la Salud Bogotá, Colombia

HTA – P&T Roundtable–North America (2017-2020)

Brian O’Rourke, PharmD
President and Chief Executive Officer,
Canadian Agency for Drugs and Technologies in Health (CADTH)
Ottawa, ON, Canada

Karen Worley, PhD
Research Leader, Comprehensive Health Insights
Humana, Inc.
Cincinnati, OH, USA

HTA Roundtable–Middle East and Africa

Chair TBD

HTA Council Working Groups

International Initiatives on the Assessments of the Value of Medical Technologies: An ISPOR HTA Council Working Group

Co-Chairs TBD

Other ISPOR Groups

HTA Special Interest Group

Chair TBD

Medical Devices and Diagnostics Special Interest Group: Value Assessment of Medical Devices Working Group

Richard Charter, MSc
Head of Market Access and Pricing Diabetes Care Europe Becton Dickinson Switzerland

Bruce Gingles
Vice-President, Global Technology Assessment and Healthcare Policy
COOK Medical, Inc
Bloomington, IN, USA

Stated-Preference Methods Special Interest Group: Stated-Preference Research in the European Union Working Group

Axel Mühlbacher, PhD
Professor of Health Economics and Health Care Management
Hochschule Neubrandenburg
Neubrandenburg, Germany

Kevin Marsh, PhD
Senior Research Scientist and Executive Director, Modeling and Simulation
Evidera
London, England, UK

HTA Committees

Asia Consortium Health Technology Assessment Agencies, Healthcare Policymakers, and Payers Committee (2018-2020)

Alexander Kostyuk, MD, PhD
Chair of the HTA Committee, Joint Commission for Quality Healthcare Services
Director, Department of Pricing for Medicines & Medical Devices at National Center for Expertise of Medicines & Medical Devices
Ministry of Health
Astana, Kazakhstan